Molecular modeling of human hepatocyte PKA (cAMP-dependent protein kinase type-II) and its structure analysis

Protein and Peptide Letters

Volumn 17, Issue 5, 2010, Pages 646-659

  Yang, Jie ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Binding sites; Bioinformatics; Computational modeling; Interaction

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE 2;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; ENZYME ACTIVE SITE; ENZYMOLOGY; GENETICS; HUMAN; LIVER CELL; METABOLISM; MOLECULAR DYNAMICS; MOLECULAR GENETICS; PROTEIN DOMAIN; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; CATALYTIC DOMAIN; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASE TYPE II; HEPATOCYTES; HUMANS; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; SEQUENCE ALIGNMENT;

PHOS;

EID: 77952008402     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986610791112792     Document Type: Article

References (94)

1. Kannan, N.; Neuwald, A.F.; Taylor, S.S. Analogous regulatory sites within the C-4 loop regions of ZAP-70 tyrosine kinase and AGC kinases. Biochim. Biophy. Acta, 2008, 1784, 27-32.
2. Kim, C.; Xuong, N.H.; Taylor, S.S. Crystal structure of a complex between the catalytic and regulatory (RIalpha) subunits of PKA. Science, 2005, 307, 690-696.
3. Scott, J.D.; Stofko, R.E.; McDonald, J.R.; Comer, J.D.; Vitalis, E.A.; Mangili, J.A. Type II regulatory subunit dimerization deter-mines the subcellular localization of the cAMP-dependent protein kinase. J. Biol. Chem., 1990, 265(35), 21561-6.
4. Neer, E.; Clapham, D. Roles of G protein subunits in transmem-brane signaling. Nature, 1988, 333, 129-134.
5. Michel, J. J.; Scott, J. D. AKAP mediated signal transduction. Annu. Rev. Pharmacol. Toxicol., 2002, 42, 235-257.
6. Burns-Hamuro, L.L.; Hamuro, Y., Kim, J.S., Sigala, P., Fayos, R., Stranz, D.D., Jennings, P.A., Taylor, S.S., Woods, V.L. Jr. Distinct interaction modes of an AKAP bound to two regulatory subunit isoforms of protein kinase A revealed by amide hydro-gen/deuterium exchange. Protein Sci., 2005, 14(12), 2982-2992.
7. Alto, N.M.; Soderling, S. H.; Hoshi, N.; Langeberg, L.K.; Fayos, R.; Jennings, P. A.; Scott, J.D. Bioinformatic design of A-kinase anchoring protein in silico: A potent and selective peptide antagonist of type II protein kinase A anchoring. Proc. Natl. Acad. Sci. U.S.A., 2003, 100(8), 4445-4450.
8. Taylor, S.S.; Buechler, J.A.; Yonemoto, W. cAMP-dependent protein kinase: Framework for a diverse family of regulatory enzymes. Annu. Rev. Biochem., 1990, 59, 971-1005.
9. Colledge, M.; Scott, J.D. AKAPs: From structure to function. Trends Cell. Biol., 1999, 9, 216-221.
10. Edwards, A.S.; Scott, J.D. A-kinase anchoring proteins: Protein kinase A and beyond. Curr. Opin. Cell Biol., 2000, 12, 217-221.
11. Taylor, S. S. cAMP-dependent Protein Kinase. J. Biol. Chem., 1989, 264, 8443-8446.
12. Alto, N.; Carlisle Michel, J.J.; Dodge, K.L.; Langeberg, L.K.; Scott, J.D. Intracellular targeting of protein kinases and phosphatases. Diabetes, 2002, 51(Suppl 3), S385-S388.
13. Gold, M.G.; Lygren, B.; Dokurno, P.; Hoshi, N.; McConnachie, G.; Taskén, K.; Carlson, C.R.; Scott, J.D.; Barford, D. Molecular basis of AKAP specificity for PKA regulatory subunits. Mol. Cell., 2006, 24(3), 383-395.
14. Wojtal, K.A.; Hoekstra, D.; van Ijzendoorn, S.C.D. Anchoring of Protein Kinase A-Regulatory Subunit II to Subapically Positioned Centrosomes Mediates Apical Bile Canalicular Lumen Development in Response to Oncostatin M but Not cAMP. Mol. Biol. Cell, 2007, 18, 2745-2754.
15. Leon, D.A.; Herberg, F.W.; Banky, P.; Taylor, S.S. A Stable a-Helical Domain at the N Terminus of the RIa Subunits of cAMP-dependent Protein Kinase Is a Novel Dimerization/Docking Motif. J. Biol. Chem., 1997, 272(45), 28431-28437.
16. Wei, D.Q.; Zhang, R.; Du, Q.S.; Gao, W.N.; Li, Y.; Gao, H.; Wang, S.Q.; Zhang, X.; Li, A.X.; Sirois, S.; Chou, K.C. Anti-SARS drug screening by molecular docking. Amino Acids, 2006, 31, 73-80.
17. Wang, J.F.; Wei, D.Q.; Li, L.; Zheng, S.Y.; Li, Y.X.; Chou, K.C. 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design Biochem. Biophys. Res. Commun., 2007, 355, 513-519.
18. Huang, R.B.; Du, Q.S.; Wang, C.H.; Chou, K.C. An in-depth analysis of the biological functional studies based on the NMR M2 channel structure of influenza A virus Biochem. Biophys. Res. Comm., 2008, 377, 1243-1247.
19. Du, Q.S.; Huang, R.B.; Wang, C.H.; Li, X.M.; Chou, K.C. Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus. J. Theor. Biol., 2009, 259, 159-164.
20. Chou, K.C.; Wei, D.Q.; Zhong, W.Z. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. Biochem. Biophys. Res. Comm., 2003, 308, 148-151.
21. Du, Q.S.; Wang, S.; Wei, D.Q.; Sirois, S.; Chou, K.C. Molecular modelling and chemical modification for finding peptide inhibitor against SARS CoV Mpro. Anal. Biochem., 2005, 337, 262-270.
22. Wei, D.Q.; Du, Q.S.; Sun, H.; Chou, K.C. Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands Biochem. Biophys. Res. Comm., 2006, 344, 1048-1055.
23. Wang, S.Q.; Du, Q.S.; Chou, K.C. Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases. Biochem. Biophys. Res. Comm., 2007, 354, 634-640.
24. Du, Q.S.; Wang, S.Q.; Chou, K.C. Analogue inhibitors by modify-ing oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus. Biochem. Biophys. Res. Comm., 2007, 362, 525-531.
25. Gong, K.; Li, L.; Wang, J.F.; Cheng, F.; Wei, D.Q.; Chou, K.C. Binding mechanism of H5N1 influenza virus neuraminidase with ligands and its implication for drug design. Med. Chem., 2009, 5, 242-249.
26. Gold, M.G.; Smith, F.D.; Scott, J.D.; Barford, D. AKAP18 contains a phosphoesterase domain that binds AMP. J. Mol. Biol., 2008, 375(5), 1329-1343.
27. Wojtal, K.A.; de Vries, E.; Hoekstra, D.; van Ijzendoorn, S.C.D. Efficient Trafficking of MDR1/P-Glycoprotein to Apical Canalicu-lar Plasma Membranes in HepG2 Cells Requires PKA-RIIa An-choring and Glucosylceramide. Mol. Biol. Cell, 2006, 17, 3638-3650.
28. Demaugre, F.; Philippe, Y.; Sar, S.; Pileire, B.; Christa, L.; Lasserre, C.; Brechot, C. HIP/PAP, a C-type lectin overexpressed in hepatocellular carcinoma, binds the RIIa regulatory subunit of cAMP-dependent protein kinase and alters the cAMP-dependent protein kinase signalling. Eur. J. Biochem., 004, 271, 3812-3820.
29. Foss, K.B.; Solberg, R.; Simard, J.; Myklebust, F.; Hansson, V.; Jahnsen, T.; Taskén, K. Molecular cloning, upstream sequence and promoter studies of the human gene for the regulatory subunit RII alpha of cAMP-dependent protein kinase. Biochim. Biophys. Acta, 1997, 1350(1), 98-108.
30. Chou, K.C. Review: Structural bioinformatics and its impact to biomedical science. Curr. Med. Chem., 2004, 11, 2105-2134.
31. Chou, K.C. Modelling extracellular domains of GABA-A recep-tors: subtypes 1, 2, 3, and 5. Biochem. Biophys. Res. Commun., 2004, 316, 636-642.
32. Wang, J.F.; Wei, D.Q.; Chen, C.; Li, Y.; Chou, K.C. Molecular modeling of two CYP2C19 SNPs and its implications for personal-ized drug design. Protein Pept. Lett., 2008, 15, 27-32.
33. Li, Y.; Wei, D.Q.; Gao, W.N.; Gao, H.; Liu, B.N.; Huang, C.J.; Xu, W.R.; Liu, D.K.; Chen, H.F.; Chou, K.C. Computational approach to drug design for oxazolidinones as antibacterial agents. Med. Chem., 2007, 3, 576-582.
34. Zhang, R.; Wei, D.Q.; Du, Q.S.; Chou, K.C. Molecular modeling studies of peptide drug candidates against SARS. Med. Chem., 2006, 2, 309-314.
35. Gao, W.N.; Wei, D.Q.; Li, Y.; Gao, H.; Xu, W.R.; Li, A.X.; Chou, K.C. Agaritine and its derivatives are potential inhibitors against HIV proteases. Med. Chem., 2007, 3, 221-226.
36. Zheng, H.; Wei, D.Q.; Zhang, R.; Wang, C.; Wei, H.; Chou, K.C. Screening for New Agonists against Alzheimer's Disease. Med. Chem., 2007, 3, 488-493.
37. Chou, K.C.; Nemethy, G.; Scheraga, H.A. Energetic approach to packing of a-helices: 2. General treatment of nonequivalent and nonregular helices. J. Am. Chem. Soc., 1984, 106, 3161-3170.
38. Chou, K.C.; Maggiora, G.M.; Nemethy, G.; Scheraga, H.A. Ener-getics of the structure of the four-alpha-helix bundle in proteins. Proc. Natl. Acad. Sci., USA, 1988, 85, 4295-4299.
39. Sirois, S.; Wei, D.Q.; Du, Q.S.; Chou, K.C. Virtual Screening for SARS-CoV Protease Based on KZ7088 Pharmacophore Points. J. Chem. Inf. Comput. Sci., 2004, 44, 1111-1122.
40. Chou, K.C. Energy-optimized structure of antifreeze protein and its binding mechanism. J. Mol. Biol., 1992, 223, 509-517.
41. Chou, K.C.; Zhou, G.P. Role of the protein outside active site on the diffusion-controlled reaction of enzyme. J. Am. Chem. Soc., 1982, 104, 1409-1413.
42. Du, Q.S.; Huang, R.B.; Chou, K.C. Review: Recent advances in QSAR and their applications in predicting the activities of chemical molecules, peptides and proteins for drug design. Curr. Protein Pept. Sci., 2008, 9, 248-259.
43. Du, Q.S.; Huang, R.B.; Wei, Y.T.; Du, L.Q.; Chou, K.C. Multiple Field Three Dimensional Quantitative Structure-Activity Relation-ship (MF-3D-QSAR). J. Comput. Chem., 2008, 29, 211-219.
44. Prado-Prado, F.J.; Gonzalez-Diaz, H.; de la Vega, O.M.; Ubeira, F.M.; Chou, K.C. Unified QSAR approach to antimicrobials. Part 3: First multi-tasking QSAR model for Input-Coded prediction, structural back-projection, and complex networks clustering of an-tiprotozoal compounds. Bioorg. Med. Chem., 2008, 16, 5871-5880.
45. Chou, K.C.; Shen, H.B. Cell-PLoc: A package of web-servers for predicting subcellular localization of proteins in various organisms. Nat. Protocols, 2008, 3, 153-162.
46. Chou, K.C.; Shen, H.B. Review: Recent progresses in protein sub-cellular location prediction. Anal. Biochem., 2007, 370, 1-16.
47. Chou, K.C.; Shen, H.B. Euk-mPLoc: a fusion classifier for large-scale eukaryotic protein subcellular location prediction by incorpo-rating multiple sites. J. Proteome Res., 2007, 6, 1728-1734.
48. Shen, H.B.; Chou, K.C. QuatIdent: A web server for identifying protein quaternary structural attribute by fusing functional domain and sequential evolution information. J. Proteome Res., 2009, 8, 1577-1584.
49. Xiao, X.; Wang, P.; Chou, K.C. Predicting protein quaternary structural attribute by hybridizing functional domain composition and pseudo amino acid composition. J. Appl. Crystallogr., 2009, 42, 169-173.
50. Chou, K.C.; Shen, H.B. FoldRate: A web-server for predicting protein folding rates from primary sequence. Open Bioinform. J., 2009, 3, 31-50.
51. Shen, H.B.; Song, J.N.; Chou, K.C. Prediction of protein folding rates from primary sequence by fusing multiple sequential features. J. Biomed. Sci. Eng., 2009, 2, 136-143.
52. Chou, K.C.; Shen, H.B. MemType-2L: A Web server for predicting membrane proteins and their types by incorporating evolution in-formation through Pse-PSSM. Biochem. Biophys. Res. Comm., 2007, 360, 339-345.
53. Shen, H.B.; Chou, K.C. EzyPred: A top-down approach for predict-ing enzyme functional classes and subclasses. Biochem. Biophys. Res. Comm., 2007, 364, 53-59.
54. Chou, K.C.; Elrod, D.W. Bioinformatical analysis of G-protein-coupled receptors. J. Proteome Res., 2002, 1, 429-433.
55. Chou, K.C. Prediction of G-protein-coupled receptor classes. J. Proteome Res., 2005, 4, 1413-1418.
56. Xiao, X.; Wang, P.; Chou, K.C. GPCR-CA: A cellular automaton image approach for predicting G-protein-coupled receptor func-tional classes. J. Comput. Chem., 2009, 30, 1414-1423.
57. Chou, K.C.; Shen, H.B. ProtIdent: A web server for identifying proteases and their types by fusing functional domain and sequen-tial evolution information. Biochem. Biophys. Res. Comm., 2008, 376, 321-325.
58. Shen, H.B.; Chou, K.C. Identification of proteases and their types. Anal. Biochem., 2009, 385, 153-160.
59. Chou, K.C. A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins. J. Biol. Chem., 1993, 268, 16938-16948.
60. Chou, K.C. Review: Prediction of HIV protease cleavage sites in proteins. Anal. Biochem., 1996, 233, 1-14.
61. Shen, H.B.; Chou, K.C. HIVcleave: a web-server for predicting HIV protease cleavage sites in proteins. Anal. Biochem., 2008, 375, 388-390.
62. Chou, K.C.; Shen, H.B. Signal-CF: a subsite-coupled and window-fusing approach for predicting signal peptides. Biochem. Biophys. Res. Comm., 2007, 357, 633-640.
63. Shen, H.B.; Chou, K.C. Signal-3L: a 3-layer approach for predicting signal peptide. Biochem. Biophys. Res. Comm., 2007, 363, 297-303.
64. Levy F.O.; Oeyen O.; Sandberg M.; Tasken K.; Eskild W.; Hans-son V.; Jahnsen T. Molecular cloning, complementary deoxyribo-nucleic acid structure and predicted full-length amino acid sequence of the hormone-inducible regulatory subunit of 3',5'-cyclic adenosine monophosphate-dependent protein kinase from human testis. Mol. Endocrinol., 1998, 2, 1364-1373.
65. Diller, T.C.; Madhusudan Xuong, N.H.; Taylor, S.S. Molecular Basis For Regulatory Subunit Diversity In cAMP-Dependent Protein Kinase: Crysta Structure Of The Type Ii Beta Regulatory Subunit. Structure, 2001, 9, 73-82.
66. Newlon, M.G.; Roy, M.; Morikis, D.; Carr, D.W.; Westphal, R.; Scott, J.D.; Jennings, P.A. A Novel Mechanism of PKA Anchoring Revealed by Solution Structures of Anchoring Complexes. EMBO J., 2001, 20, 1651-1662.
67. Zheng, J.; Knighton, D.R.; Xuong, N.H.; Taylor, S.S.; Sowadski, J.M.; Ten Eyck, L.F. Crystal structures of the myristylated catalytic subunit of cAMP-dependent protein kinase reveal open and closed conformations. Protein Sci., 1993, 2, 1559-1573.
68. Klussmann, E.; Edemir, B.; Pepperle, B.; Tamma, G.; Henn, V.; Klauschenz, E.; Hundsrucker, C.; Maric, K.; Rosenthal, W. Ht31: the first protein kinase A anchoring protein to integrate protein kinase A and Rho signaling. FEBS Lett., 2001, 507, 264-268.
69. J.E.; Rawls, J.F.; Saxe, C.L. III. SCAR, a WASP-related protein, isolated as a suppressor of receptor defects in late Dictyos-telium development. J. Cell Biol., 1998, 142, 1325-1335.
70. Yang, J.; Zhan, C.Y.; Dong, X.C.; Yang, K., Wang, F.X. Interaction of Human Fibrinogen Receptor (GPIIb-IIIa) with Decorsin. Acta Pharmacologica Sinica, 2004, 25 (8), 1096-1104.
71. Zhan, C.Y.; Yang, J.; Dong, X.C.; Wang, Y.L. Molecular Modeling of Purinergic Receptor P2Y12 and Interaction with its antagonists. J. Mol. Graphics. Model., 2007, 26, 20-31.
72. Yang, J.; Dong, X.C.; Leng, Y. Application of FTTP to alpha-helix or beta-strand motifs. J. Theor. Biol., 2006, 242, 199-219.
73. Ficarro, S.; Chertihin, O.; Westbrook, V.A.; White, F.; Jayes, F.; Kalab, P.; Marto, J.A.; Shabanowitz, J.; Herr, J.C.; Hunt, D.F.; Visconti, P.E. Phosphoproteome analysis of capacitated human sperm. Evidence of tyrosine phosphorylation of a kinase-anchoring protein 3 and valosin-containing protein/p97 during capacitation. J. Biol. Chem., 2003, 278(13), 11579-11589.
74. Holz, G.G.; Chepurny, O.G.; Schwede, F. Epac-selective cAMP analogs: New tools with which to evaluate the signal transduction properties of cAMP-regulated guanine nucleotide exchange factors. Cell. Signal., 2008, 20, 10-20.
75. Chou, K.C.; Watenpaugh, K.D.; Heinrikson, R.L. A Model of the complex between cyclin-dependent kinase 5 (Cdk5) and the activa-tion domain of neuronal Cdk5 activator. Biochem. Biophys. Res. Comm., 1999, 259, 420-428.
76. Zhang, J.; Luan, C.H.; Chou, K.C.; Johnson, G.V.W. Identification of the N-terminal functional domains of Cdk5 by molecular trunca-tion and computer modeling. Proteins Struct. Funct. Genet., 2002, 48, 447-453.
77. Chou, K.C. Insights from modelling the 3D structure of the ex-tracellular domain of alpha7 nicotinic acetylcholine receptor. Bio-chem. Biophys. Res. Comm., 2004, 319, 433-438.
78. Chou, K.C. Molecular therapeutic target for type-2 diabetes. J. Proteome Res., 2004, 3, 1284-1288.
79. Chou, K.C.; Wei, D.Q.; Du, Q.S.; Sirois, S.; Zhong, W.Z. Review: Progress in computational approach to drug development against SARS. Curr. Med. Chem., 2006, 13, 3263-3270.
80. Du, Q.S.; Sun, H.; Chou, K.C. Inhibitor design for SARS coronavi-rus main protease based on distorted key theory. Med. Chem., 2007, 3, 1-6.
81. Housaindokht, M.R.; Bozorgmehr, M.R.; Bahrololoom, M. Analysis of ligand binding to proteins using molecular dynamics simulations. J. Theor. Biol., 2008, 254, 294-300.
82. Danial, N.N.; Gramm, C.F.; Scorrano, L.; Zhang, C.Y.; Krauss, S.; Ranger, A.M.; Datta, S.R.; Greenberg, M.E.; Licklider, L.J.; Lowell, B.B.; Gygi, S.P.; Korsmeyer, S.J. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature, 2003, 424, 952-956.
83. Yang, J. Molecular modeling of human BAD and its interaction with PKAc or PP1c. J. Theor. Biol., 2009, 257, 159-169.
84. Huang, L.J.; Wang, L.; Ma, Y.; Durick, K.; Perkins, G.; Deerinck, T.J.; Ellisman, M.H.; Taylor, S.S. NH2-Terminal targeting motifs direct dual specificity A-kinase-anchoring protein 1 (D-AKAP1) to either mitochondria or endoplasmic reticulum. J. Cell Biol., 1999, 145(5), 951-959.
85. Strausberg, R.L.; Feingold, E.A.; Grouse, L.H.; Derge, J.G.; Klaus-ner, R.D.; Collins, F.S.; Wagner, L.; Shenmen, C.M.; Schuler, G.D.; Altschul, S.F.; Zeeberg, B.; Buetow, K.H.; Schaefer, C.F.; Bhat, N.K.; Hopkins, R.F.; Jordan, H.; Moore, T.; Max, S.I.; Wang, J.; Marra, M.A. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. U.S.A., 2002, 99, 16899-16903.
86. Harada, H.; Becknell, B.; Wilm, M.; Mann, M.; Huang, L.J.-S.; Taylor, S.S.; Scott, J.D.; Korsmeyer, S.J. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell, 1999, 3, 413-422.
87. Tamaki, T. Glucose-Stimulated cAMP-Protein Kinase A Pathway in Yeast Saccharomyces cerevisiae. J. Biosci. Bioeng., 2007, 104 (4), 245-250.
88. R.M.; Taylor, S.S. Dissecting the cooperative reassociation of the regulatory and catalytic subunits of cAMP-dependent protein kinase. Role of Trp-196 in the catalytic subunit. J. Biol. Chem., 1997, 272, 31998-32005.
89. Berman, H.M.; Ten Eyck, L.F.; Goodsell, D.S.; Haste, N.M.; Kor-nev, A.; Taylor, S. The cAMP binding domain: An ancient signaling module. Proc. Natl. Acad. Sci. U.S.A., 2005, 102, 45-50.
90. Anand, G.S.; Law, D.; Mandell, J.G.; Snead, A.N.; Tsigelny, I.; Taylor, S.S., Ten Eyck, L.F., Komives, E.A. Identification of the protein kinase A regulatory RI-catalytic subunit interface by am-ide H/2 H exchange and protein docking. Proc. Natl. Acad. Sci. U.S.A., 2003, 100, 13264-13269.
91. Herberg, F. W.; Doyle, M.L.; Cox, S.; Taylor, S.S. Dissection of the nucleotide and metal-phosphate binding sites in cAMP-dependent protein kinase. Biochemistry, 1999, 38, 6352-6360.
92. Heller, W.T.; Vigil, D.; Brown, S.; Blumenthal, D.K.; Taylor, S.S.; Trewhella, J. C subunits binding to the protein kinase A RI alpha dimer induce a large conformational change. J. Biol. Chem., 2004, 279, 19084-19090.
93. Atkinson, R.A.; Saudek, V.; Huggins, J.P.; Pelton, J. T. 1H NMR and circular dichroism studies of the N-terminal domain of cyclic GMP dependent protein kinase: a leucine/isoleucine zipper. Biochemistry, 1991, 30, 9387-9385.
94. Taskén, K.; Stokka, A.J. The molecular machinery for cAMP-dependent immunomodulation in T-cells. Biochem. Soc. Trans., 2006, 34, 476-479.